- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02827669
One Drop Experts Program for Type 2 Diabetes Self-Management: Impact on A1c
December 10, 2019 updated by: Jessie Juusola, Evidation Health
The One Drop Experts Program for Type 2 Diabetes Self-Management Impact on A1c trial is a 12-week long, prospective, intent-to-treat study that aims to evaluate the impact of the One Drop app and Experts program on HbA1c levels for individuals with uncontrolled Type 2 diabetes.
A secondary objective will be to evaluate participants who utilize an Apple Watch in combination with the One Drop app and Experts program, and assess whether this group is more engaged or experiences a different impact as compared to participants who utilized the One Drop app and Experts program only.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
297
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Mateo, California, United States, 94401
- Evidation Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Self-reported Type 2 diabetes diagnosis
- Has not changed treatment regimen in the last 3 months
- HbA1c levels ≥ 7.5% by self-report and verified by lab test
- Motivated to use a daily diabetes self-management coaching program to improve diabetes control
- Owns and uses an iPhone with a compatible iOS operating system and has successfully downloaded and used a smartphone application previously
Exclusion Criteria:
- Current use of a smartphone application to manage their diabetes
- Currently participating in a diabetes self-management education or coaching program
- Currently pregnant
- Does not understand English
- History of serious mental illness or dementia
- Has severe diabetic complications such as severe diabetic retinopathy, chronic kidney disease (stages 4-5), severe diabetic neuropathy, diabetic foot ulcer or infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: One Drop Experts Program
Participants will be able to use the One Drop mobile app and One Drop Experts program on their smartphones.
The One Drop mobile app is a diabetes management platform that allows users to track and log their blood glucose levels, medications, food, and activities.
One Drop Experts is a diabetes education and coaching program delivered entirely through the One Drop mobile application.
|
|
Experimental: One Drop Experts Program + Apple Watch
An Apple Watch will be provided to study participants in this arm.
In addition to using the One Drop mobile app and One Drop Experts program on their smartphones, participants will also be able to engage with the app and program on their Apple Watch.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HbA1c
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
February 1, 2017
Study Registration Dates
First Submitted
July 5, 2016
First Submitted That Met QC Criteria
July 6, 2016
First Posted (Estimate)
July 11, 2016
Study Record Updates
Last Update Posted (Actual)
December 12, 2019
Last Update Submitted That Met QC Criteria
December 10, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EH-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 2 Diabetes Mellitus
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
AstraZenecaRecruiting
Clinical Trials on One Drop Experts Program
-
Chandra Osborn, PhD, MPHUnknownDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | PreDiabetesUnited States
-
Informed Data Systems, Inc.Mannkind CorporationUnknownDiabetes Mellitus, Type 2United States
-
Fundacio d'Investigacio en Atencio Primaria Jordi...UnknownDepressive Disorder | Musculoskeletal Pain | Chronic PainSpain
-
Kasr El Aini HospitalCompletedPelvic Floor Muscle Weakness | Delivery; Trauma | Pelvic Floor; Perineal Rupture, ObstetricEgypt
-
Hospices Civils de LyonRecruiting
-
Hospices Civils de LyonCompletedFunctional Neurological Symptom DisorderFrance
-
University of Maryland, BaltimoreAerie PharmaceuticalsCompletedOcular Hypertension | Suspect GlaucomaUnited States
-
Universidad de AlmeriaUniversidad de GranadaCompleted
-
Ain Shams UniversityCompletedCongenital Heart DiseaseEgypt
-
University of ZurichCompletedKidney Transplantation | Rental TransplantationSwitzerland